NCT04070027

Brief Summary

Hip osteoarthritis is associated with joint pain, physical disability, decreased muscle strength and poor health status, and the most common cause for total hip arthroplasty. No studies have investigated the effect of total hip arthroplasty compared to non-surgical treatment in patients with end-stage hip osteoarthritis. This comparison is of upmost importance as it is unknown whether non-surgical treatment may be used as an alternate to surgery. The purpose of this study is to investigate whether total hip arthroplasty followed by standard care is superior to progressive resistance training for improving hip function and pain in patients with end-stage hip osteoarthritis. The hypothesis is that patients treated with total hip arthroplasty will improve more than patients treated with progressive resistance training.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Sep 2019Jun 2026

First Submitted

Initial submission to the registry

August 12, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

September 2, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2022

Completed
4.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

2.7 years

First QC Date

August 12, 2019

Last Update Submit

May 13, 2025

Conditions

Keywords

Total Hip ArthroplastyTotal Hip ReplacementExerciseProgressive Resistance TrainingStrength TrainingHip Joint

Outcome Measures

Primary Outcomes (1)

  • Change in the Oxford Hip Score (OHS) from baseline to 6 months

    The OHS is a 12-item patient-reported outcome measure designed to assess hip function and pain within the last four weeks among patients suffering from hip osteoarthritis in one score. The total score ranges from 0 to 48, with higher scores indicating better disease status.

    6 months

Secondary Outcomes (9)

  • Change in the Hip disability and Osteoarthritis Outcome Score (HOOS) pain subscale from baseline to 6 months

    6 months

  • Change in the HOOS symptoms subscale from baseline to 6 months

    6 months

  • Change in the HOOS activities of daily living (ADL) function subscale from baseline to 6 months

    6 months

  • Change in the HOOS quality-of-life subscale from baseline to 6 months

    6 months

  • Change in the HOOS sports and recreation subscale from baseline to 6 months

    6 months.

  • +4 more secondary outcomes

Other Outcomes (14)

  • Change in hip pain intensity on a 101-point Visual Analogue Scale (VAS) from baseline to 6 months

    6 months

  • Change in EuroQol Group 5-dimension 5-level (EQ-5D-5L) from baseline to 6 months

    6 months

  • Change in number of patients using pain medication related to the hip from baseline to 6 months

    6 months

  • +11 more other outcomes

Study Arms (2)

Total Hip Arthroplasty

ACTIVE COMPARATOR

A standard fast-track multimodal surgical program comprising patient information, optimised pain management, and early mobilisation. Total hip arthroplasty (THA) will be performed by experienced orthopaedic surgeons in accordance with the standard posterior surgical approach. Patients will receive standard postoperative rehabilitation consisting of either a standard leaflet with a hospital-specific home-based exercise program aimed at increasing hip muscle strength and range of motion or, if considered necessary, a referral to supervised hip-specific exercise therapy delivered at private physiotherapist clinics or municipal rehabilitation. Furthermore, postsurgical procedures will follow hospital-specific procedures ranging from no postsurgical control to postsurgical assessment of the hip and rehabilitation at the physiotherapy department (after six-weeks).

Procedure: Total Hip Arthroplasty

Progressive Resistance Training

ACTIVE COMPARATOR

A 12-week supervised explosive-type progressive resistance training (PRT) program with two training sessions a week. All training sessions will be conducted in municipal rehabilitation centres with one-to-one supervision and ≥48 hours of rest in between sessions. The standardised PRT program will consist of warm-up on a stationary bicycle (10 min) followed by four lower extremity exercises (50 min). Exercises will be performed unilaterally with as full range of motion as possible in sets of three separated by 60 sec of rest in the following order: leg press, hip extension, hip flexion, and hip abduction. Patients will be instructed to complete the concentric phase of each repetition "as fast as possible", maintain full extension for 1 sec, and perform the eccentric phase in 2-3 sec. Hip-related pain up to 5 rated on a Numerical Rating Scale (0-10) is considered acceptable during exercises. After the 12-weeks, patients will be offered three-months of optional unsupervised PRT.

Other: Progressive Resistance Training

Interventions

Total hip arthroplasty following standard procedures.

Also known as: Total Hip Replacement
Total Hip Arthroplasty

Progressive resistance training based on available evidence on patients with hip osteoarthritis and designed in accordance with the "American College of Sports Medicine" (ACSM) recommendations for progression models in resistance training aiming at inducing muscle hypertrophy and increasing muscle strength and power.

Also known as: Strength Training, Exercise
Progressive Resistance Training

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥50 years
  • Clinical history and symptoms consistent with primary hip osteoarthritis (including hip osteoarthritis due to mild hip dysplasia that may be treated with standard components) and radiographic verified hip osteoarthritis defined as joint space narrowing \<2 mm
  • Considered eligible for total hip arthroplasty by an orthopaedic surgeon (i.e. duration of symptoms \>3 months, hip related pain, functional impairment or decreased range of motion (ROM), and attempted treatment with analgesics)

You may not qualify if:

  • Severe walking deficits (dependency of two crutches or walker)
  • Body Mass Index \>35 kg/m2
  • Planned other lower extremity surgery within six months
  • Cancer diagnosis and receiving chemo-, immuno- or radiotherapy
  • Neurological diseases (e.g. previous stroke, multiple sclerosis, Parkinson's, Alzheimer's).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Orthopaedic Surgery, Aarhus University Hospital (AUH)

Aarhus, 8200, Denmark

Location

Department of Orthopaedic Surgery, Naestved Hospital

Næstved, 4700, Denmark

Location

Department of Orthopaedic Surgery and Traumatology, Odense University Hospital (OUH)

Odense, 5000, Denmark

Location

Depatment of Orthopaedic Surgery, Vejle Hospital

Vejle, 7100, Denmark

Location

Related Publications (4)

  • Bryld ES, Christiansen L, Ingwersen KG, Overgaard S, Mikkelsen LR, Mechlenburg I, Frydendal T. Training load and pain response during progressive resistance training in patients with hip osteoarthritis in the PROHIP trial. Osteoarthr Cartil Open. 2025 Oct 4;7(4):100690. doi: 10.1016/j.ocarto.2025.100690. eCollection 2025 Dec.

  • Frydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Varnum C, Graversen AE, Kjaersgaard-Andersen P, Revald PH, Hofbauer C, Bieder MJ, Qassim H, Munir MS, Jakobsen SS, Nielsen SM, Ingwersen KG, Overgaard S. Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis. N Engl J Med. 2024 Oct 31;391(17):1610-1620. doi: 10.1056/NEJMoa2400141.

  • Frydendal T, Thomsen KS, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG, Myburgh C. Patient and public involvement to inform the protocol of a clinical trial comparing total hip arthroplasty with exercise: an exploratory qualitative case study. BMJ Open. 2023 Apr 24;13(4):e070866. doi: 10.1136/bmjopen-2022-070866.

  • Frydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG. Total hip arthroplasty versus progressive resistance training in patients with severe hip osteoarthritis: protocol for a multicentre, parallel-group, randomised controlled superiority trial. BMJ Open. 2021 Oct 22;11(10):e051392. doi: 10.1136/bmjopen-2021-051392.

MeSH Terms

Conditions

Osteoarthritis, HipMotor Activity

Interventions

Arthroplasty, Replacement, HipResistance TrainingExercise

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis ImplantationExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Thomas Frydendal, PT, MSc

    Vejle Hospital and University of Southern Denmark

    PRINCIPAL INVESTIGATOR
  • Søren Overgaard, Prof., MD

    Odense University Hospital and University of Southern Denmark

    STUDY DIRECTOR
  • Inger Mechlenburg, Prof., DMSc

    Aarhus University Hospital and Aarhus University

    STUDY CHAIR
  • Kim Gordon Ingwersen, PT, PhD

    Vejle Hospital and University of Southern Denmark

    STUDY CHAIR
  • Lone Ramer Mikkelsen, PT, PhD

    Silkeborg Regional Hospital

    STUDY CHAIR
  • Robin Christensen, Prof., PhD

    The Parker Institute and Odense University Hospital

    STUDY CHAIR
  • Claus Varnum, PhD, MD

    Vejle Hospital

    STUDY CHAIR
  • Henrik Morville Schrøder, PhD, MD

    Naestved Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2019

First Posted

August 28, 2019

Study Start

September 2, 2019

Primary Completion

May 5, 2022

Study Completion (Estimated)

June 1, 2026

Last Updated

May 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Anonymised patient-level data for the primary and all secondary outcome measures will be made available if required by the scientific journal, in which the results of the trial are published.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available after publication of the trial.
Access Criteria
Data access will be reviewed by the author group. Requestors will be required to sign a Data Access Agreement.

Locations